Flash Glucose Monitoring: The Future Is Here
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
cannot believe that it has been more than two de- cades since we first evaluated real-time continuous glucose monitoring (CGM)-(GlucoWatch Ò ) in patients with type 1 diabetes (T1D).The first real-time CGM (GlucoWatch), which uses a reversed iontophoresis to measure interstitial glucose, was approved to be used for 12 h by the Food and Drug Administration (FDA) in 1999. 1,2Since then, several advancements have led to the availability of many CGM systems MiniMed iPro Ò , Enlite 2 Ò , Enlite Enhanced, Enlite 3 ( Medtronic, Northridge, CA), DexCom STS (Short Term Sensor), Dexcom 3, 7, Gen 4 and 5 Ò (Dexcom, San Diego, CA), and Navigator Ò (Abbott Diabetes Care, Alameda, CA). 3,4All of the CGMs were approved as adjunctive and needed 2-4 calibrations a day. 3,4Bailey et al. highlighted the accuracy of CGMs and clinical implications of accuracy in this supplement. 5Most recently, for the first time, Dexcom Gen 5 was approved as nonadjunctive, and CGM data could be used for insulin dosing decisions, although it still needs 2 calibrations a day. 6Large, multicenter, randomized clinical trials that showed the utility of using CGM were detailed by Slattery et al. in this supplement. 7The first major breakaway came with the launch of FreeStyle Libre ProÔ (professional) or personal-a patch glucose sensor, needing no calibration (factory calibrated) that lasts for 14 days. 8,9reeStyle LibreÔ professional or personal, commonly referred to as ''flash glucose monitoring'' system, where the data are available on demand at any time during 14 days and needs no calibration during its use.Only FreeStyle Libre Pro is currently approved by FDA for professional use. 8Wright et al. emphasized the benefits of flash glucose monitoring professional use with real case series in this supplement. 10he flash glucose monitoring has had a significant uptake in European countries wherever it has been made available.In fact, more recently, I had two of my patients who bought their flash glucose monitoring personal in Europe, and they were very ''impressed'' with its accuracy, ease of use, and liked that flash glucose monitoring did not need any calibrations.There are many reasons for early success and rapid uptake of flash glucose monitoring.These include the following:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685 · cited 1×
“The first major breakaway came with the launch of FreeStyle Libre Pro (professional) or personal—a patch glucose sensor, needing no calibration (factory calibrated) that lasts for 14 days.(8,9) FreeStyle Libre professional or personal, commonly referred to as ‘‘flash glucose monitoring’’ system, where the data are ava…”
Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis
Gorst, C., Kwok, C. S., Aslam, S., Buchan, I., Kontopantelis, E., Myint, P. K., Heatlie, G., Loke, Y., Rutter, M. K., & Mamas, M. A. (2015) · Diabetes Care · doi:10.2337/dc15-1188 · Cited by 530
Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
Fonseca, V. A., Grunberger, G., Anhalt, H., Bailey, T. S., Blevins, T., Garg, S. K., Handelsman, Y., Hirsch, I. B., Orzeck, E. A., Roberts, V. L., et al. (2016) · Endocrine Practice · doi:10.4158/ep161392.cs · Cited by 195
Ólafsdóttir, A. F., Attvall, S., Sandgren, U., Dahlqvist, S., Pivodic, A., Skrtic, S., Theodorsson, E., & Lind, M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0392 · Cited by 173
Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes
Slattery, D., & Choudhary, P. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0051 · Cited by 87
Clinical Implications of Accuracy Measurements of Continuous Glucose Sensors
Bailey, T. S. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0050 · Cited by 60
Cited by
Glycaemic variability in diabetes: clinical and therapeutic implications
Ceriello, A., Monnier, L., & Owens, D. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30136-0 · Cited by 588
Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus
Lin, R., Brown, F., James, S., Jones, J., & Ekinci, E. (2021) · Diabetic Medicine · doi:10.1111/dme.14528 · Cited by 197
Paris, I., Henry, C., Pirard, F., Gérard, A., & Colin, I. M. (2018) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.23 · Cited by 84
Castellana, M., Parisi, C., Di Molfetta, S., Di Gioia, L., Natalicchio, A., Perrini, S., Cignarelli, A., Laviola, L., & Giorgino, F. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001092 · Cited by 84
Recent advances in computational tools and resources for the self-management of type 2 diabetes
Moonian, O., Jodheea-Jutton, A., Khedo, K. K., Baichoo, S., Nagowah, S. D., Nagowah, L., Mungloo-Dilmohamud, Z., & Cheerkoot-Jalim, S. (2020) · Informatics for Health and Social Care · doi:10.1080/17538157.2018.1559168 · Cited by 15
Metadata
- Authors
- Garg, S. K., & Akturk, H. K.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2017-05
- Volume
- 19
- Issue
- S2
- Pages
- S-1-S-3
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W2617579124
- Cited by
- 31
- References
- 8
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Flash Glucose Monitoring: The Future Is Here. https://app.cochat.ai/papers/10.1089/dia.2017.0098
- The paper
- Garg, S. K., & Akturk, H. K. (2017). Flash Glucose Monitoring: The Future Is Here. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2017.0098
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.